Abiopharma

News list

Williams John Edward 🟡 adjusted position in 826 shares (1 derivative) of MKS INC (MKSI) at $269.89 Transaction Date: Apr 17, 2026 | Filing ID: 000061

Full text

News bot April 20, 2026, 3:34 p.m.
🔍 Williams John Edward (Executive)

Company: MKS INC (MKSI)

Report Date: 2026-04-17
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,741
- Total shares sold: 2,567
Detailed Transactions and Holdings:
- Acquired 1,741 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,380.81 | transaction_form_type: 4 | Footnotes: F1
- Sold 826 shares of Common Stock at $269.89 per share (Direct)
  Date: 2026-04-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,554.84 | transaction_form_type: 4 | Footnotes: F2
- Sold 1,741 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,812.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3
Footnotes:
- F1: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of MKS Inc.
- F2: These shares were withheld by MKS Inc. to satisfy the tax withholding obligations triggered by the vesting of RSUs and do not represent a discretionary trade by the reporting person.
- F3: These RSUs vest in two equal annual installments commencing on April 17, 2025, provided that if, in any vesting year, April 17th is not a business day, such vesting shall occur on the next business day.